Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
4.890
+0.260 (5.62%)
At close: Aug 22, 2025, 4:00 PM
4.900
+0.010 (0.20%)
After-hours: Aug 22, 2025, 7:49 PM EDT
Immuneering Market Cap
Immuneering has a market cap or net worth of $177.60 million as of August 22, 2025. Its market cap has increased by 425.37% in one year.
Market Cap
177.60M
Enterprise Value
155.24M
1-Year Change
425.37%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $177.60M, a decrease of -51.45%. That is a compound annual growth rate of -16.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 177.60M | 159.99% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |